Accessibility Menu
 
PolyPid logo

PolyPid

(NASDAQ) PYPD

Current Price$4.40
Market Cap$83.58M
Since IPO (2020)-99%
5 Year-98%
1 Year+62%
1 Month+3%

PolyPid Financials at a Glance

Market Cap

$83.58M

Revenue (TTM)

$0.00

Net Income (TTM)

$34.17M

EPS (TTM)

$-2.26

P/E Ratio

-1.93

Dividend

$0.00

Beta (Volatility)

0.92 (Low)

Price

$4.40

Volume

0

Open

$4.40

Previous Close

$4.40

Daily Range

$4.37 - $4.44

52-Week Range

$2.30 - $5.12

PYPD News

No articles available.

PYPD: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About PolyPid

Industry

Pharmaceuticals

Employees

75

CEO

Dikla Czaczkes Akselbrad, MBA, CPA

Headquarters

Petah Tikva, 4959376, IL

PYPD Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

-366%

Return on Capital

-1%

Return on Assets

-2%

Earnings Yield

-51.81%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$83.58M

Shares Outstanding

19.08M

Volume

0

Short Interest

0.00%

Avg. Volume

61.26K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$32.97M

EBITDA

$31.86M

Operating Cash Flow

$0.00

Capital Expenditure

$0.00

Free Cash Flow

$0.00

Cash & ST Invst.

$12.93M

Total Debt

$2.80M

PolyPid Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$83.58M

N/A

Market Cap/Employee

$1.47M

N/A

Employees

57

N/A

Net Income

$8.47M

+0.6%

EBITDA

$8.12M

+1.2%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$10.14M

+68.3%

Accounts Receivable

$0.00

N/A

Inventory

$1.11M

N/A

Long Term Debt

$647.00K

-66.1%

Short Term Debt

$2.15M

-72.1%

Return on Assets

-1.53%

N/A

Return on Invested Capital

-1.09%

N/A

Free Cash Flow

$0.00

N/A

Operating Cash Flow

$0.00

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MAIAMAIA Biotechnology, Inc.
$1.40+7.28%
ANVSAnnovis Bio, Inc.
$2.23+10.95%
VERUVeru Inc.
$2.21+3.76%
PDSBPDS Biotechnology Corporation
$0.60+12.77%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$41.68+0.10%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.15+0.09%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$80.49-0.10%
IBITiShares Bitcoin Trust
$38.42+0.02%

Questions About PYPD

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.